Executive Functioning at Baseline Prospectively Predicts Depression Treatment Response

Area of Science:

• Neuroscience
• Clinical Psychology
• Psychiatry

Background:

• Predicting treatment response in depression is crucial for effective clinical decision-making.
• Existing predictors lack sufficient strength and clinical utility.
• This study explored clinical and cognitive markers for predicting treatment outcomes in depressed adults.

Purpose of the Study:

• To investigate the predictive power of clinical and cognitive markers for treatment response in depressed adults.
• To assess if executive functioning assessments can identify individuals at risk for poor treatment outcomes.

Main Methods:

• A sample of 75 depressed adults receiving standard treatment (medication and psychotherapy) was studied.
• Clinical data, including baseline Patient Health Questionnaire (PHQ-9) scores and education, were collected.
• Computerized neuropsychological tests, including the Parametric Go/No-Go task, assessed cognitive functions.

Main Results:

• A 46% decline in PHQ-9 scores was observed at follow-up, with 56% of patients classified as responders.
• Baseline PHQ-9 scores and education predicted treatment response.
• Faster processing speed with interference resolution (go reaction time) significantly predicted treatment outcomes, accounting for 12% of the variance.

Conclusions:

• Executive functioning assessments, particularly processing speed, can aid in identifying depressed individuals likely to respond to standard treatments.
• Integrating cognitive assessments into clinical practice may improve treatment selection and patient outcomes.